TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 392 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $21,244,000 | -9.6% | 1,076,742 | -21.2% | 1.24% | +14.4% |
Q3 2019 | $23,501,000 | -24.1% | 1,366,325 | -21.9% | 1.08% | -14.8% |
Q2 2019 | $30,960,000 | +4.0% | 1,749,147 | +16.8% | 1.27% | +2.0% |
Q1 2019 | $29,755,000 | +729.3% | 1,497,934 | +602.1% | 1.24% | +288.1% |
Q4 2018 | $3,588,000 | – | 213,337 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 30,201 | $3,149,000 | 19.29% |
MANAGED ASSET PORTFOLIOS, LLC | 1,399,878 | $20,046,000 | 2.75% |
Clean Yield Group | 251,220 | $3,597,000 | 1.27% |
Mondrian Investment Partners LTD | 4,319,715 | $60,476,000 | 1.24% |
Sippican Capital Advisors | 80,490 | $1,153,000 | 0.96% |
TFG Asset Management GP Ltd | 1,275,656 | $18,268,000 | 0.83% |
Lumbard & Kellner, LLC | 132,516 | $1,898,000 | 0.74% |
BRANDES INVESTMENT PARTNERS, LP | 2,109,846 | $30,213,000 | 0.65% |
CAUSEWAY CAPITAL MANAGEMENT LLC | 1,601,046 | $22,927,000 | 0.55% |
Ridgewood Investments LLC | 33,378 | $478,000 | 0.31% |